Multigene assays to improve assessment of recurrence risk and benefit from chemotherapy in early-stage colon cancer: has the time finally arrived, or are we still stage locked?

Source:http://linkedlifedata.com/resource/pubmed/id/20679612

J. Clin. Oncol. 2010 Sep 1 28 25 3904-7

Download in:

View as

General Info

PMID
20679612